Tronox Holdings

Rising Compliance Costs And Fierce Chinese Competition Will Hamper Margins

AnalystLowTarget

Not Invested

Community Contributor

Published

08 May 25

AnalystLowTarget's Fair Value

US$1.11

197.8% overvalued

10 Sep

US$3.31

-77.6%

-19.1%

-77.6%

-19.1%

You can edit this narrative until May 12 6:02 AM. Then, changes will post as Updates.

Author's Valuation

US$1.11197.8% overvalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$1.11

197.8% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

1.72%

Chemicals revenue growth rate

0.66%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.32%

Calculation

US$25.69m

Earnings '28

9.81x

PE Ratio '28

US$251.98m

Market Cap '28

US$251.98m

Market Cap '28

160.34m

No. shares '28

US$1.57

Share Price '28

US$1.57 Share Price '28

Discounted to 2025 @ 12.32% p.a.

US$1.11

Fair Value '25